Biogen : BIIB

All Biogen Articles

606 Articles

Lee Jackson | Oct 31, 2015 at 9:20 AM EDT

Massive Biotech Purchase Highlights Recent Insider Buying

As we are just about through with the spooky month on Wall Street, and the third-quarter earnings are starting to…

Chris Lange | Oct 27, 2015 at 8:10 AM EDT

Short Sellers Become More Selective on Leading Biotechs

The October 15 short interest data have been compared with the previous figures, and short interest mixed in these selected…

Chris Lange | Oct 21, 2015 at 9:40 AM EDT

Biogen Beats on Both Top and Bottom Lines

Biogen reported better-than-expected third-quarter financial results Wednesday before the market opened.

Chris Lange | Oct 18, 2015 at 9:05 AM EDT

6 Must-See Earnings Previews for the Coming Week

24/7 Wall St. has put together a preview of GM, Yahoo and some of the major companies reporting their quarterly…

Lee Jackson | Oct 16, 2015 at 9:25 AM EDT

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

These three top biotech names are very good bets for investors looking to add high-quality companies with less volatility and…

Paul Ausick | Oct 12, 2015 at 4:04 PM EDT

The 52-Week Low Club for Monday

ThinkstockOctober 12, 2015: Here are four stocks trading with heavy volume among 25 equities making new 52-week lows today. VMware…

Chris Lange | Oct 12, 2015 at 8:20 AM EDT

Short Sellers Increase Bets in Major Biotechs

The September 30 short interest data have been compared with the previous figures, and short interest increased in most of…

Chris Lange | Sep 26, 2015 at 9:25 AM EDT

How the Top Biotechs Handled the Valuation Shock

24/7 Wall St. has taken a look at some of the largest biotech companies and highlighted the damage that a…

Chris Lange | Sep 25, 2015 at 8:05 AM EDT

Short Sellers Increase Bets in Major Biotech

The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks…

Lee Jackson | Sep 11, 2015 at 8:20 AM EDT

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

In a new and very comprehensive report, Jefferies starts coverage on biotechs with some very targeted stock selections.

Chris Lange | Sep 11, 2015 at 8:05 AM EDT

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased…

Jon C. Ogg | Sep 10, 2015 at 10:50 AM EDT

Biogen Follows Gilead With Large Debt Offering

ThinkstockAre biotech companies going to become the next big companies saddled with debt? Most likely not, but two debt offerings…

Chris Lange | Aug 26, 2015 at 8:55 AM EDT

Short Sellers Become More Focused in Major Biotechs

The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of…

Chris Lange | Aug 20, 2015 at 10:25 AM EDT

Applied Genetic Solidifies Deal With Biogen

Applied Genetic Technologies announced that the Biogen equity investment as part of their collaboration has closed.

Chris Lange | Aug 12, 2015 at 8:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech…

1 … 21 22 23 24 25 … 41

Biogen : BIIB

All Biogen Articles

Massive Biotech Purchase Highlights Recent Insider Buying

Short Sellers Become More Selective on Leading Biotechs

Biogen Beats on Both Top and Bottom Lines

6 Must-See Earnings Previews for the Coming Week

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

The 52-Week Low Club for Monday

Short Sellers Increase Bets in Major Biotechs

How the Top Biotechs Handled the Valuation Shock

Short Sellers Increase Bets in Major Biotech

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

Short Sellers Increase Bets in Major Biotechs

Biogen Follows Gilead With Large Debt Offering

Short Sellers Become More Focused in Major Biotechs

Applied Genetic Solidifies Deal With Biogen

Short Sellers Run for Cover From Major Biotechs

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

Gambling Creator Bluffin Bob Rejected a $30M+ Casino Deal and Never Looked Back

The Market Is Panicking on Broadcom. This Is Why I Keep Buying The Stock

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

Gambling Creator Bluffin Bob Rejected a $30M+ Casino Deal and Never Looked Back

Biogen : BIIB

All Biogen Articles

Massive Biotech Purchase Highlights Recent Insider Buying

Short Sellers Become More Selective on Leading Biotechs

Biogen Beats on Both Top and Bottom Lines

6 Must-See Earnings Previews for the Coming Week

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

The 52-Week Low Club for Monday

Short Sellers Increase Bets in Major Biotechs

How the Top Biotechs Handled the Valuation Shock

Short Sellers Increase Bets in Major Biotech

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

Short Sellers Increase Bets in Major Biotechs

Biogen Follows Gilead With Large Debt Offering

Short Sellers Become More Focused in Major Biotechs

Applied Genetic Solidifies Deal With Biogen

Short Sellers Run for Cover From Major Biotechs

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

Gambling Creator Bluffin Bob Rejected a $30M+ Casino Deal and Never Looked Back

The Market Is Panicking on Broadcom. This Is Why I Keep Buying The Stock

Featured Reads

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)